Skip to main content
Erschienen in: Journal of Neurology 3/2014

01.03.2014 | Original Communication

COL4A2 mutation causing adult onset recurrent intracerebral hemorrhage and leukoencephalopathy

verfasst von: Bence Gunda, Manuele Mine, Tibor Kovács, Csilla Hornyák, Dániel Bereczki, György Várallyay, Gábor Rudas, Marie-Pierre Audrezet, Elisabeth Tournier-Lasserve

Erschienen in: Journal of Neurology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Type IV collagen α1 and α2 chains form heterotrimers that constitute an essential component of basement membranes. Mutations in COL4A1, encoding the α1 chain, cause a multisystem disease with prominent cerebrovascular manifestations, including porencephaly, bleeding-prone cerebral small vessel disease, and intracranial aneurysms. Mutations in COL4A2 have only been reported in a few porencephaly families so far. Herein, we report on a young adult patient with recurrent intracerebral hemorrhage, leukoencephalopathy, intracranial aneurysms, nephropathy, and myopathy associated with a novel COL4A2 mutation. We extensively investigated a 29-year-old male patient with recurrent deep intracerebral hemorrhages causing mild motor and sensory hemisyndromes. Brain MRI showed deep intracerebral hemorrhages of different age, diffuse leukoencephalopathy, multiple cerebral microbleeds and small aneurysms of the carotid siphon bilaterally. Laboratory work-up revealed significant microscopic hematuria and elevation of creatine-kinase. Genetic testing found a de novo glycine mutation within the COL4A2 triple helical domain. The presented case completes the spectrum of cerebral and systemic manifestations of COL4A2 mutations that appears to be very similar to that in COL4A1 mutations. Therefore, we emphasize the importance of screening both COL4A1 and COL4A2 in patients showing recurrent intracerebral hemorrhage of unknown etiology, particularly if associated with leukoencephalopathy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kuo DS, Labelle-Dumais C, Gould DB (2012) COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets. Hum Mol Genet 21:R97–R110PubMedCentralCrossRefPubMed Kuo DS, Labelle-Dumais C, Gould DB (2012) COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets. Hum Mol Genet 21:R97–R110PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Vahedi K, Alamowitch S (2011) Clinical spectrum of type IV collagen (COL4A1) mutations: a novel genetic multisystem disease. Curr Opin Neurol 24:63–68CrossRefPubMed Vahedi K, Alamowitch S (2011) Clinical spectrum of type IV collagen (COL4A1) mutations: a novel genetic multisystem disease. Curr Opin Neurol 24:63–68CrossRefPubMed
3.
Zurück zum Zitat Gould DB, Phalan FC, van Mil SE et al (2006) Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 354:1489–1496CrossRefPubMed Gould DB, Phalan FC, van Mil SE et al (2006) Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 354:1489–1496CrossRefPubMed
4.
Zurück zum Zitat Lanfranconi S, Markus HS (2010) COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review. Stroke 41:e513–e518CrossRefPubMed Lanfranconi S, Markus HS (2010) COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review. Stroke 41:e513–e518CrossRefPubMed
5.
Zurück zum Zitat Vahedi K, Kubis N, Boukobza M et al (2007) COL4A1 mutation in a patient with sporadic, recurrent intracerebral hemorrhage. Stroke 38:1461–1464CrossRefPubMed Vahedi K, Kubis N, Boukobza M et al (2007) COL4A1 mutation in a patient with sporadic, recurrent intracerebral hemorrhage. Stroke 38:1461–1464CrossRefPubMed
6.
Zurück zum Zitat Coupry I, Sibon I, Mortemousque B, Rouanet F, Mine M, Goizet C (2010) Ophthalmological features associated with COL4A1 mutations. Arch Ophthalmol 128:483–489CrossRefPubMed Coupry I, Sibon I, Mortemousque B, Rouanet F, Mine M, Goizet C (2010) Ophthalmological features associated with COL4A1 mutations. Arch Ophthalmol 128:483–489CrossRefPubMed
7.
Zurück zum Zitat Plaisier E, Gribouval O, Alamowitch S et al (2007) COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Eng J Med 357:2687–2695CrossRef Plaisier E, Gribouval O, Alamowitch S et al (2007) COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Eng J Med 357:2687–2695CrossRef
8.
Zurück zum Zitat Verbeek E, Meuwissen ME, Verheijen FW et al (2012) COL4A2 mutation associated with familial porencephaly and small-vessel disease. Eur J Hum Genet 20:844–851PubMedCentralCrossRefPubMed Verbeek E, Meuwissen ME, Verheijen FW et al (2012) COL4A2 mutation associated with familial porencephaly and small-vessel disease. Eur J Hum Genet 20:844–851PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Yoneda Y, Haginoya K, Arai H et al (2012) De novo and inherited mutations in COL4A2, encoding the type IV collagen alpha2 chain cause porencephaly. Am J Hum Genet 90:86–90PubMedCentralCrossRefPubMed Yoneda Y, Haginoya K, Arai H et al (2012) De novo and inherited mutations in COL4A2, encoding the type IV collagen alpha2 chain cause porencephaly. Am J Hum Genet 90:86–90PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Murray LS, Lu Y, Taggart A et al (2013) Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke. Hum Mol Genet. doi:10.1093/hmg/ddt418 [Epub ahead of print] Murray LS, Lu Y, Taggart A et al (2013) Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke. Hum Mol Genet. doi:10.​1093/​hmg/​ddt418 [Epub ahead of print]
11.
Zurück zum Zitat Jeanne M, Labelle-Dumais C, Jorgensen J et al (2012) COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. Am J Hum Genet 90:91–101PubMedCentralCrossRefPubMed Jeanne M, Labelle-Dumais C, Jorgensen J et al (2012) COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. Am J Hum Genet 90:91–101PubMedCentralCrossRefPubMed
Metadaten
Titel
COL4A2 mutation causing adult onset recurrent intracerebral hemorrhage and leukoencephalopathy
verfasst von
Bence Gunda
Manuele Mine
Tibor Kovács
Csilla Hornyák
Dániel Bereczki
György Várallyay
Gábor Rudas
Marie-Pierre Audrezet
Elisabeth Tournier-Lasserve
Publikationsdatum
01.03.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 3/2014
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-013-7224-4

Weitere Artikel der Ausgabe 3/2014

Journal of Neurology 3/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.